Literature DB >> 19161771

Redo valvular surgery in elderly patients.

Manjula Maganti1, Vivek Rao, Susan Armstrong, Christopher M Feindel, Hugh E Scully, Tirone E David.   

Abstract

BACKGROUND: Elderly patients older than the age of 75 constitute 13% of the population that undergoes cardiac surgery at our institution and represent the fastest growing population in Ontario. We have witnessed an increasing proportion of elderly patients being referred for repeat surgical intervention for valvular heart disease. We determined the perioperative and long-term outcomes in elderly patients undergoing redo cardiac valve surgery.
METHODS: A retrospective review of our institutional database identified 112 patients aged 75 years or older (mean age, 78 +/- 3 years; range, 75 to 89 years) who underwent redo valve surgery between 1990 and 2004. All patients presented with a previous surgical intervention on the valve of interest. The mean follow-up was 5 +/- 4 years and was 100% complete.
RESULTS: Eighty-eight patients (79%) had isolated valve surgery at their primary operation whereas 24 patients (21%) had concomitant coronary artery bypass grafting at the time of their initial valve surgery. At reoperation, 74 patients (66%) underwent single valve surgery (40 aortic valve, 34 mitral valve), 33 patients (29.5%) required double valve surgery, and 5 patients (4.5%) had triple valve surgery. Thirty-three patients (29.5%) required concomitant coronary artery bypass grafting, among whom 14 patients had a previous coronary artery bypass graft surgery. There were 12 operative (10.7%) and 47 late deaths (42%). Cardiovascular events were the cause of death in 32 patients (54% of all deaths). Overall survival at 5 years was 67% +/- 5%. The freedom from valve-related mortality and morbidity was 86% +/- 4% at 5 years. Mean intensive care eunit stay was 3.7 +/- 4.5 days, and postoperative hospital stay was 15 +/- 12 days.
CONCLUSIONS: Redo valvular surgery in an elderly cohort can be performed with acceptable morbidity and mortality. Although 5-year survival is lower than that observed with a younger patient population, it is still likely higher than expected survival without surgical intervention. Despite increased resource utilization, elderly patients should be offered redo surgical intervention for valvular heart disease.

Entities:  

Mesh:

Year:  2009        PMID: 19161771     DOI: 10.1016/j.athoracsur.2008.09.030

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  19 in total

Review 1.  Minimally invasive reoperative aortic valve replacement: a systematic review and meta-analysis.

Authors:  Kevin Phan; Jessie J Zhou; Nithya Niranjan; Marco Di Eusanio; Tristan D Yan
Journal:  Ann Cardiothorac Surg       Date:  2015-01

Review 2.  Transseptal Transcatheter Mitral Valve Replacement for Post-Surgical Mitral Failures.

Authors:  Marvin H Eng; Dee Dee Wang
Journal:  Interv Cardiol       Date:  2018-05

Review 3.  In Search of the Ideal Valve: Optimizing Genetic Modifications to Prevent Bioprosthetic Degeneration.

Authors:  Benjamin Smood; Hidetaka Hara; David C Cleveland; David K C Cooper
Journal:  Ann Thorac Surg       Date:  2019-03-02       Impact factor: 4.330

Review 4.  Valve-in-valve implantations: is this the new standard for degenerated bioprostheses? Review of the literature.

Authors:  Krys Milburn; Vinayak Bapat; Martyn Thomas
Journal:  Clin Res Cardiol       Date:  2014-01-21       Impact factor: 5.460

Review 5.  Tissue Valve Degeneration and Mechanical Valve Failure.

Authors:  Andrew C W Baldwin; George Tolis
Journal:  Curr Treat Options Cardiovasc Med       Date:  2019-06-14

6.  Outcome after redo-mitral valve replacement in adult patients: a 10-year single-centre experience.

Authors:  Hunaid A Vohra; Robert N Whistance; Apostolos Roubelakis; Andrew Burton; Clifford W Barlow; Geoffrey M K Tsang; Steve A Livesey; Sunil K Ohri
Journal:  Interact Cardiovasc Thorac Surg       Date:  2012-01-31

Review 7.  Transcatheter valve-in-valve therapies: patient selection, prosthesis assessment and selection, results, and future directions.

Authors:  Manuel Wilbring; Konstantin Alexiou; Sems-Malte Tugtekin; Bjoern Sill; Gregor Simonis; Klaus Matschke; Utz Kappert
Journal:  Curr Cardiol Rep       Date:  2013-03       Impact factor: 2.931

8.  Predictors of in-hospital mortality following redo cardiac surgery: Single center experience.

Authors:  Yucel Colkesen; Isa Coskun; Murat Cayli; Oner Gulcan
Journal:  Interv Med Appl Sci       Date:  2015-09-28

9.  Redo aortic valve surgery versus transcatheter valve-in-valve implantation for failing surgical bioprosthetic valves: consecutive patients in a single-center setting.

Authors:  Magdalena Erlebach; Michael Wottke; Marcus-André Deutsch; Markus Krane; Nicolo Piazza; Ruediger Lange; Sabine Bleiziffer
Journal:  J Thorac Dis       Date:  2015-09       Impact factor: 2.895

10.  Right mini-thoracotomy approach reduces hospital stay and transfusion of mitral or tricuspid valve reoperation with non-inferior efficacy: evidence from propensity-matched study.

Authors:  Qing Wang; Xiaofei Xue; Jie Yang; Qian Yang; Pei Wang; Liaoyuan Wang; Peng Zhang; Suyu Wang; Jing Wang; Jibin Xu; Jian Xiao; Zhinong Wang
Journal:  J Thorac Dis       Date:  2018-08       Impact factor: 2.895

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.